Valuation (33%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 19.17 | N/A |
PEG Ratio (TTM) | -1.05 | N/A |
P/S Ratio (TTM) | 24.32 | N/A |
P/B Ratio (TTM) | 0.76 | N/A |
P/FCF Ratio (TTM) | -29.21 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (40%) |
Company | Industry |
---|---|---|
ROA (TTM) | 3.39% | N/A |
ROE (TTM) | 3.33% | N/A |
Net Profit Margin (TTM) | 124.88% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -17.67% | N/A | N/A |
Revenue | -25.00% | N/A | N/A |
Net Income | -29.06% | N/A | N/A |
Cash Flow | -22.76% | N/A | N/A |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.02 | N/A |
Quick Ratio (TTM) | 0.02 | N/A |
D/E Ratio (TTM) | 0.07 | N/A |
Interest Coverage (TTM) | -1.17 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | 2.67 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |